Clinical Trials Browser

Phase 2 × Melanoma × Immunohistochemistry × Clear all

NCT00514085 2023-08-04

Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma

Phase 2 Completed

Melanoma

NCT01316692 2016-05-30

Aurora A Kinase Inhibitor MLN8237 in Treating Patients With Unresectable Stage III-IV Melanoma

Phase 2 Terminated

12 enrolled 10 charts

Melanoma

NCT00602199 2011-05-16

ABT-510 in Treating Patients With Metastatic Melanoma

Phase 2 Completed

Melanoma